After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.

by Eric Fitzsimmons

Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.

by Kyle Bagenstose

News coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.

by Laura Gesualdi Gilmore

Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.

As people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.

by Thomas Celona

Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.

by Kevin McLaughlin

Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.

by Marci A. Landsmann

Tailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.

by Eric Fitzsimmons

While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.

by Thomas Celona

U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.

by Kevin McLaughlin